Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats

Thrombosis Research

Volumn 89, Issue 3, 1998, Pages 107-114

  Takada, Yumiko ^a   Urano, Tetsumei ^a   Takahashi, Hiroshi ^a   Nagai, Nobuo ^a   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenaline; AVP; ELT; PAI; Stress; t PA

Indexed keywords

ADRENALIN; ARGIPRESSIN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; ENZYME ACTIVITY; FIBRINOLYSIS; HEMOSTASIS; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WATER IMMERSION;

EID: 0032004328     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00300-9     Document Type: Article

References (26)

1. 1. Macfarlane RG, Biggs R. Observations on fibrinolysis. Spontaneous activity associated with surgical operations, trauma, etc. Lancet 1946; ii:862-4.
2. 2. Schneider RA, Zangari VM. Variations in clotting time, relative viscosity, other physiochemical properties of the blood accompanying physical and emotional stress in the normotensive and hypertensive subject. Psychosom Med 1951;13:289-303.
3. 3. Truelove, SC. Fibrinolysis and eosinophil count. Clin Sci 1951;10:229-40.
4. 4. Friedman M, Rosenman RH, Carrol V. Changes in serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation 1958;17: 852-61.
5. 5. Ogston G, McDonald GA, Fullerton HW. The influence of anxiety in tests of blood coagulability and fibrinolytic activity. Lancet 1962;ii: 521-3.
6. 6. Trichopoulos D, Katsouyanni K, Zavitsanos X, Tzonou A, Dalla-Vorgia P. Psychological stress and fatal heart attack: The Athens' (1981) earthquake natural experiment. Lancet 1983;i:441-4.
7. 7. Wolf S. Psychosocial forces in myocardial infarction and sudden death. Circulation 1969;40 (Suppl 4):74-83.
8. 8. Mathews KA, Haynes SG. Type A behavior pattern and coronary disease risk: Update and critical evaluation. Am J Epidemiol 1986; 123:923-60.
9. 9. Herman JP, Cullinan WE. Neurocircuitory of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosci 1997;20:78-84.
10. 10. Malyszko J, Urano T, Takada Y, Takada A. Time-dependent changes in platelet aggregation, fibrinolytic activity, and peripheral serotonergic measures in rats subjected to water immersion restraint stress. Haemostas 1994; 24:236-42.
11. 11. Malyszko J, Urano T, Takada Y, Takada A. Stress-dependent changes in fibrinolysis, serotonin and platelet aggregation in rats. Life Sci 1994;54:1275-80.
12. 12. Urano T, Malyszko J, Serizawa K, Kojima Y, Takada Y, Takada A. Electric-foot-shock induced the suppression of fibrinolytic activity in rats. Thromb Res 1994;74:595-603.
13. 13. Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thromb Haemost 1990;63:82-6.
14. 14. Urano T, Sumiyoshi K, Pietraszek MH, Takada Y, Takada A. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA. Thromb Haemost 1991; 66:474-8.
15. 15. Takada A, Shizume K, Ozawa T, Takahashi S, Takada Y. Characterization of various antibodies against tissue plasminogen activator using highly sensitive enzyme immunoassay. Thromb Res 1988;42:63-72.
16. 16. Takada Y, Takada A. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma. Thromb Res 1988;(Suppl VIII):15-22.
17. 17. Mefford IN, Ward MM, Miles L, Taylor B, Chesney MA, Keegan DL, Barchas JD. Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection. Life Sci 1981;28:477-83.
18. 18. Nagai N, Nagai K, Chun S-J, Shimizu K, Takezawa M, Tsuji M, et al. Roles of the suprachiasmatic nucleus and vasoactive intestinal peptide in the response of plasma arginine vasopressin to osmotic challenge. Endocrinol 1996;137: 504-7.
19. 19. Williams RBJ. Psychological factors in coronary artery disease: Epidemiological evidence. Circulation 1987;76(Suppl 1):117-23.
20. 20. Wilhelmsen L, Svarsudd K, Korsan-Bengsten K, Larsson B, Tibblin G. Fibrinogen as a cardiovascular risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
21. 21. Kannel WB, D'Agostino BB, Belanger AJ. Fibrinogen and risk of cardiovascular disease. JAMA 1987;258:1183-6.
22. 22. Markowe HLJ, Marmot MG, Shipley MJ, Bulpit CJ, Meade TW, Stirling Y, et al. Fibrinogen: A possible link between social class and coronary heart disease. Br Med J 1985;291:1312-4.
23. 23. Rosengren A, Wilhelmsen L, Lennart W, Tsipogianni A, Teger-Nilsson A-C, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. Br Med J 1990;300:634-7.
24. 24. Urano T, Cho M, Takahashi S, Sumiyoshi K, Nakamura M, Mori T, et al. Changes of parameters in fibrinolytic system caused by mental stress. Thromb Res 1990;60:501-7.
25. 25. Feldman S, Conforti N, Itzik A, Weidenfeld J. Differential effect of amygdaloid lesions on CRF-41, ACTH and corticosterone responses following neural stimuli. Brain Res 1994; 658:21-6.
26. 26. Li HY, Ericsson A, Sawchenko P. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 1996;93:2359-64.